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Summary
DNA tumor virus oncoproteins bind and inactivate Rb by interfering with the Rb/HDAC1 interaction. Che-1 is a recently
identified human Rb binding protein that inhibits the Rb growth suppressing function. Here we show that Che-1 contacts
the Rb pocket region and competes with HDAC1 for Rb binding site, removing HDAC1 from the Rb/E2F complex in vitro
and from the E2F target promoters in vivo. Che-1 overexpression activates DNA synthesis in quiescent NIH-3T3 cells
through HDAC1 displacement. Consistently, Che-1-specific RNA interference affects E2F activity and cell proliferation in
human fibroblasts but not in the pocket protein-defective 293 cells. These findings indicate the existence of a pathway of
Rb regulation supporting Che-1 as the cellular counterpart of DNA tumor virus oncoproteins.
Introduction a conserved Leu-X-Cys-X-Glu (LXCXE) sequence (De Caprio et
al., 1988; Hu et al., 1990; Whyte et al., 1988). Inactivation of
The Rb tumor suppressor plays a critical role in the control of the E2F1 target gene transcription entails the recruitment of Rb
cell proliferation and differentiation (Weinberg, 1995). Mutations by E2F1 to the promoters of these genes. This Rb recruitment
of the Rb gene are present in a variety of human cancers, masks the activation domain of E2F1 and prevents its interac-
including retinoblastoma, osteosarcoma, and small-cell lung tions with the general transcription machinery (Hagemeier et
cancer (Weinberg, 1995; Riley et al., 1994). Rb and the related al., 1993). Before cells proceed into the S phase of the cell
proteins p130 and p107 control cell cycle progression through cycle, Rb is phosphorylated at multiple sites by cyclin-depen-
dent kinases (Cdks). This phosphorylation leads to Rb inactiva-their interactions with the E2F family of transcription factors
(Dyson, 1998; Harbour and Dean, 2000). E2F is known to acti- tion, release of E2F1, and subsequent transcriptional activation
of its target genes (Dyson, 1998). Recently, an additional mecha-vate transcription of a number of genes required for the S phase
of the cell cycle, including cyclin A, cyclin E, dihydrofolate reduc- nism of Rb-mediated transcriptional repression of E2F1 target
genes has been proposed (Brehm et al., 1998; Luo et al., 1998;tase (Dhfr) and thymidyne kinase (Tk) (Dyson, 1998; Nevins et
al., 1997). The interaction with E2F1 and the ability of Rb to Magnaghi-Jaulin et al., 1998). Indeed, Rb was shown to recruit
class I histone deacetylase proteins (HDAC 1–3) that can repressprevent cell proliferation depends on its functional domains (res-
idues 379–792), termed A and B motifs or the “pocket” region transcription by removing acetyl groups from histone octamers.
This removal facilitates the condensation of nucleosomes into(Weinberg, 1995; De Gregori et al., 1997). The pocket can inter-
act with E2F1 and several oncoproteins, such as SV40 Large chromatin, which blocks access to transcription factors and
leads to gene repression (Kingston and Narlikar, 1999; WoffleT antigen, adenovirus E1A, and papilloma virus E7, that inacti-
vate the pocket proteins by a direct physical association through and Hayes, 1999; Kornberg and Lorch, 1999; Hassig et al.,
S I G N I F I C A N C E
The retinoblastoma gene (Rb) was identified over a decade ago as the first tumor suppressor. It plays a fundamental role in cellular
regulation and is the target of tumorigenic alterations in many cell types. Although Rb mutations are not frequent, disruption of Rb
activity occurs in the majority of human tumors through several mechanisms, including viral oncoprotein binding and deregulated
Rb phosphorylation by mutations of cyclins or cyclin-dependent kinase inhibitors. In this paper we propose a novel mechanism of
Rb inactivation through its binding with the human Che-1 protein that antagonizes the recruitment of HDAC1 on Rb, supporting Che-1
as the first cellular protein behaving as a viral oncoprotein.
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1997). HDAC1 and HDAC2 bind to the pocket region of Rb 1998). HDAC1 contacts Rb through a degenerate LXCXE motif,
and this interaction can be disrupted by Rb phosphorylation orthrough an LXCXE-like motif (i.e., IXCXE) (Magnaghi-Jaulin et
al., 1998; Ferreira et al., 1998), whereas HDAC3 does not contain by DNA virus oncogenes, which also possess a LXCXE motif
(Luo et al., 1998; Ferreira et al., 1998; Zhang et al., 2000). Thoughthis motif, even though it binds Rb (Lai et al., 1999). During the
cell cycle, phosphorylation of Rb by Cdks triggers sequential Che-1 does not have a LXCXE motif, it contains an amino acid
sequence (aa 305–323) with a strong homology to the region thatintramolecular interactions that progressively disrupt the Rb/
HDAC1 connections by blocking G1 progression (Harbour et includes this motif (Figure 2A), suggesting that the interactions of
Che-1 and HDAC1 with Rb might be mutually exclusive events.al., 1999). Moreover, peptides containing the LXCXE motif pres-
ent in the viral SV40 large T or E7 oncoproteins displace HDAC1 To test this hypothesis, 35S-labeled HDAC1 protein was incu-
bated with bacterial recombinant GST-Rb fusion protein in thefrom Rb (Brehm et al., 1998; Magnaghi-Jaulin et al., 1998; Fer-
reira et al., 1998), indicating that viral transforming proteins can absence or presence of increasing amounts of recombinant His-
Che-1. HDAC1 was specifically retained on GST-Rb beads,interrupt the Rb/HDAC1 interaction through Rb binding.
By means of a two-hybrid screening with the subunit 11 of but this interaction was gradually abolished in the presence of
recombinant Che-1 (Figure 2B). To confirm this result, humanthe RNA polymerase II as bait, we have recently cloned the
human Che-1 gene (Fanciulli et al., 2000). The Che-1 gene prod- Rb-negative Saos-2 cells were cotransfected with myc-HDAC1
and increasing amounts of myc-Che-1 expression vectors, anduct is a nuclear protein involved in transcription control and is
highly conserved during evolution (Lindfors et al., 2000; Thomas cell lysates were incubated with GST-Rb beads. As shown in
Figure 2C, Che-1 strongly bound to Rb and decreased the Rb/et al., 2000; Page et al., 1999; Kogel et al., 1999). We can
demonstrate that Che-1 can form complexes with Rb by two HDAC1 interaction in a dose-dependent manner. The relative
densitometric analyses showed that Che-1 displaces more thandistinct portions (Fanciulli et al., 2000), one of which is highly
homologous to the SV40 Large T region required for Rb inactiva- 70% of HDAC1 from GST-Rb. Consistent with these results,
Che-1 and HDAC1 cotransfection in Saos-2 cells led to a markedtion. Furthermore, the binding of Che-1 to Rb interferes with
the Rb-mediated inhibition of E2F1 transcriptional activity in decrease in the ability of GST-Rb to retain histone deacetylase
activity from cell extracts (Figure 2D). To further characterize thetransient luciferase reporter assays and with the Rb-mediated
inhibition of colony formation in the Rb-negative Saos-2 cells Che-1-mediated displacement of HDAC1 from Rb, competition
experiments were performed with synthetic peptides. The Che-1(Fanciulli et al., 2000). In this report, we describe a mechanism
by which Che-1 exerts its inhibitory effect on Rb. Che-1 contacts region 305–323, the sequence homologous to HDAC1 (see Fig-
ure 2A), was employed together with a nonspecific control pep-the pocket region and removes HDAC1 from the Rb/E2F1 com-
plex, affecting the activation of E2F-dependent promoters and tide. As shown in Figure 2E, Che-1 305–323 peptide markedly
decreased HDAC1 binding in a dose-dependent manner. In-cell proliferation.
deed, the amount of HDAC1 associated to GST-Rb decreased
to background levels, indicating that this peptide had disruptedResults
the majority of Rb/HDAC1 complexes.
The results obtained raised the question of whether Che-1The pocket region of Rb is essential for Che-1/Rb interaction
We had previously shown that Che-1 binds Rb in vitro and in binds Rb with sufficiently high affinity to justify HDAC1 displace-
ment. Thus, use was made of synthetic peptides correspondingvivo (Fanciulli et al., 2000). Several cellular and viral proteins
bind and inactivate Rb within the pocket region (Hu et al., 1990; to “LXCXE” motifs of HDAC1, SV40 Large T, and the Che-1
305–323 region to specifically inhibit the Rb/HDAC1 interactionHuang et al., 1990; Kaelin et al., 1990); thus, we investigated
whether this region is also relevant for the association with in GST pull-down assays. Consistent with the results of Mag-
naghi-Jaulin et al. (1998), Large T was a better inhibitor thanChe-1. GST-Rb fusion proteins encompassing various domains
(Figures 1A and 1C) were employed for in vitro binding experi- the homologous HDAC1 sequence (Figure 2F). Significantly, the
inhibitory ability of Che-1 peptide was similar to that of Largements with 35S-labeled Che-1 (Figure 1B). The entire wild-type
pocket region bound efficiently to Che-1 (Figure 1B), whereas T (Figure 2F), indicating a higher affinity of Che-1 to Rb than
HDAC1. These data indicate that the physical interaction be-the mutant GST-Rb 379–928 C706F, which does not bind E1A,
exhibited a diminished binding to Che-1. Comparable results tween Che-1 and Rb can interfere with HDAC1 recruitment and
suggest that Che-1 can function in the same manner as LXCXE-were obtained with GST-Rb 379–928 ex21, which lacks exon
21. GST-Rb 1–379 and GST-Rb 792–928, encoding for the N- containing viral oncoproteins.
The relevance of the Che-1 305–323 region in HDAC1 dis-and the C-terminal domains respectively, did not bind Che-1
at all. These results indicate that Che-1 binds to the Rb pocket placement from Rb was further evaluated by employing a Che-1
mutant (Che-1) with this region deleted. As previously shown,region and that the pocket integrity is required for the interaction.
Che-1 contacts Rb at two distinct portions (Fanciulli et al., 2000);The pocket domains of the Rb family members p107 and
therefore, as expected, Che-1 expressed in Saos-2 cells stillp130 are similar to that of Rb. Thus, we analyzed whether these
retained the ability to bind GST-Rb. However, it showed a re-proteins were also able to interact with Che-1. Total cell extracts
duced capacity in competing with HDAC1 for Rb binding (Figurefrom NIH-3T3 fibroblasts were used for coimmunoprecipitation
2G). These results were confirmed when GST-Rb-associatedanalyses. As shown in Figure 1D, Che-1 bound the three mem-
histone deacetylase activity from the same cell extracts wasbers of the pocket proteins family.
analyzed (data not shown). Taken together, these results indi-
cate that Che-1 competes with HDAC1 on the Rb binding siteChe-1 competes with HDAC1 for Rb interaction
through the 305–323 region through its 305–323 region.
To evaluate the biological relevance of this finding, Che-1To repress transcription, Rb can recruit HDAC1 protein into the
E2F complexes (Brehm et al., 1998; Magnaghi-Jaulin et al., was engaged in the same assays we previously employed to
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Figure 1. Rb contacts Che-1 through the pocket region
A: Coomassie blue stain of purified GST and GST-Rb proteins (as indicated by *). B: Labeled Che-1 was subjected to GST pull-down analysis using GST or
GST-Rb fusion proteins beads indicated in A. C: Schematic representation of GST-Rb fusion proteins used for the analysis. Rb 379–928 C706F represents the
mutation C→F at the amino acid 706, whereas Rb 379–928ex21 represents deletion mutant lacking exon 21. D: Che-1 coimmunoprecipitates the three
members of the pocket family. Cell lysates from NIH 3T3 fibroblasts were immunoprecipitated with anti-Che-1 polyclonal antibody or preimmune serum
and analyzed by Western blot using specific anti-Rb, anti-p130, and p107 polyclonal antibodies as described in Experimental Procedures.
study the Che-1 activity on Rb (Fanciulli et al., 2000). In contrast Che-1 (Figure 3A), and chromatin immunoprecipitation (ChIP)
assays were performed by immunoprecipitating crosslinked ge-to wild-type Che-1, Che-1 expression in Saos-2 cells did not
nomic DNA with an anti-HDAC1 specific antibody. Immunopre-counteract the Rb inhibitory effect on E2F1 transacting function
cipitated DNA was analyzed by PCR utilizing promoter-specificon the Dhfr promoter in transient luciferase reporter expression
primers that encompass the E2F binding sites (see Experimentalassays (Supplemental Figure S1A at http://www.cancercell.org/
Procedures) under conditions of linear amplification (Figure 3B).cgi/content/full/2/5/387/DC1). Moreover, Che-1 did not inter-
As shown in Figure 3C, HDAC1 levels were low or undetectablefere with the growth suppression activity of Rb in colony forming
on the E2F target cyclin A, Dhfr, and Tk gene promoters andassays (Supplemental Figures S1A and S1C), suggesting that
increased after Rb overexpression, confirming the HDAC re-the Che-1 305–323 region and its activity on HDAC1 recruitment
cruitment by this tumor suppressor, but were low or undetect-by Rb represents one possible mechanism through which Che-1
able in cells cotransfected with Rb and Che-1. Either Rb or Rbinhibits Rb functions.
and Che-1 transfection did not affect the E2F-unresponsive
Gapdh promoter, used as negative control.Che-1 displaces the HDAC1 associated to E2F target
gene promoters in vivo It has been demonstrated that recruitment of HDAC1 by Rb
to gene promoters decreases their level of histone acetylationTo evaluate whether Che-1 can decrease the level of HDAC1
at the E2F binding sites of E2F-responsive gene promoters in (Luo et al., 1998). Thus, we evaluated whether Che-1 mediated
displacement of HDAC1 was associated with the presence ofvivo, Saos-2 cells were transfected either with Rb or with Rb and
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Figure 2. Che-1 competes with HDAC1 for Rb binding
A: Sequence alignment of Che-1 and LXCXE-containing proteins. Amino acid sequences spanning the LXCXE motif of 5 viral proteins and HDAC1–3.
Conserved LXCXE motifs are in bold and boxed. Conserved acid residues N-terminal to the LXCXE motif, and conserved hydrophobic and acid residues
C-terminal to the motif, are in bold, italic, and boxed. B: Labeled HDAC1 was subjected to GST pull-down analysis using GST or GST-Rb beads with or
without () 5 or 10 g of recombinant histidine-tagged Che-1 (amount indicated by the height of the black triangle). C: In vitro binding analysis of GST-
Rb fusion protein with lysates from Saos-2 cells transiently transfected with myc-tagged HDAC1 (5 g) or with HDAC1 and 1, 2, or 5 g of myc-tagged
Che-1 (amount indicated by the height of the black triangle). The membrane was analyzed by Western blot using specific monoclonal antibody anti-
myc. Numbers show percentages of HDAC1 binding to GST-Rb deduced by densitometric analysis of the blot. D: Che-1 reduces histone deacetylase
activity associated with Rb. Column diagram shows deacetylase activity recovered by performing experiments as described in C. Data are presented as
the mean  SD from three independent experiments performed in duplicate. E: Lysates from Saos-2 cells transiently transfected with myc-tagged HDAC1
were subjected to a pull-down analysis using GST-Rb beads. Before GST pull-down analysis, beads were incubated with or without () 5, 10, or 15 g of
Che-1 or control peptide (amount indicated by the height of the blank triangle). F: Inhibition of Rb/HDAC1 interaction by an excess of “Rb-interacting
motifs”: labeled HADC1 (5  105 cpm) was subjected to pull-down analysis using GST-Rb beads in the absence or in the presence of increasing amounts
(5, 10, 15 g) of the indicated synthetic peptides described in the Experimental Procedures. The radioactivity associated with pellet of each sample was
evaluated by counting on an open channel, and the value of the pellet of each sample was corrected by subtracting the count of a background sample
(GST alone). Data are presented as the mean  SD from three independent experiments performed in duplicate. G: Che-1 does not displace HDAC1
from Rb. In vitro binding analysis of GST-Rb fusion protein with lysates from Saos-2 cells transiently transfected with myc-tagged HDAC1 alone, HDAC1 and
myc-tagged Che-1, or HDAC1 and myc-tagged Che-1 lacking region 305–323. The membrane was analyzed by Western blot using specific monoclonal
antibody anti-myc.
acetylated histones on in vivo promoters. ChIP was performed and ChIP correspond to a real regulation of the expression of
by immunoprecipitating the DNA with an anti-acetylated histone these genes in vivo, a semiquantitative reverse transcriptase-
H3 antibody. Control vector-transfected Saos-2 cells exhibited PCR was carried out. The expression levels of Dhfr, Tk, and
high levels of acetylated histone H3 in association with the E2F Cyclin A mRNA were measured in Saos-2 cells upon overex-
binding sites of the analyzed promoters (Figure 3D). Overexpres- pression of Rb or Rb and Che-1. Consistent with the previous
sion of Rb decreased acetylated histone H3 association with analysis, these genes were specifically downregulated following
the same promoters, but not with the Gapdh unrelated promoter. Rb overexpression, but not upon coexpression of Rb and Che-1
In contrast, coexpression of Rb and Che-1 completely abolished
(Figure 3E).the effects of Rb (Figure 3D). These results are consistent with
the hypothesis that Che-1 efficiently competes with HDAC1 for
Exogenous Che-1-inducible expression affects E2FRb binding.
activity and cell proliferationFinally, to evaluate whether the results observed by per-
The experiments described above were carried out by usingforming transcriptional analysis (Supplemental Figures S2A–
S2C at http://www.cancercell.org/cgi/content/full/2/5/387/DC1) protein overexpression in transient assays. To test whether
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Figure 3. Che-1 displaces the HDAC1 from E2F target gene promoters in vivo
A: Lysates from Saos-2 cells transiently transfected with empty vector, pCMV Rb or pCMV Rb, and myc-Che-1, respectively, were subjected to Western
blot analysis with anti-Rb and anti-myc antibodies to verify protein expression. B, C, and D: Lysates from Saos-2 cells transfected as described in A were
subjected to chromatin immunoprecipitation using specific polyclonal antibodies anti-HDAC1 (C) or anti-acetylated histone H3 (D). B: Increasing amounts
of input samples (0.1, 0.2, 0.4, 0.8 l) were used as template in PCR amplifications performed using primers specific for the different promoters including
E2F binding sites. “DHFR” indicates dihydrofolate reductase, “TK” indicates thymidine kinase, and “GAPDH” indicates glyceraldehyde-3-phosphate dehydro-
genase. Immunoprecipitates from each sample were analyzed by PCR, and a sample representing linear amplification (0.2–0.4 l) of the total input
chromatin (Input) was included in the PCRs as a control. Additional control included a precipitation performed with no specific IgGs. E: RNA from Saos-2
cells transiently transfected as described in A was isolated. Equal amounts of RNA (RNA input) were analyzed by RT-PCR (25 cycles) for the expression of
cyclin A, Dhfr, Tk, and Gapdh. The RT control lanes represent RT-PCR in the absence of reverse transcription.
physiological levels of Che-1 can affect HDAC1/Rb binding on accelerated the cell cycle reentry, as evaluated by simultaneous
flow cytometric analyses for DNA synthesis (BrdUrd incorpora-E2F-dependent promoters, we generated NIH-3T3 cells that
conditionally express human Che-1 in a tetracycline-regulated tion) and DNA content (propidium iodide staining) (Figure 4E).
These results were confirmed by immunoblots for the levels ofway. Human and murine Che-1 are highly homologous, but the
human gene possesses an extra exon coding for aa 146–177 cyclins A and D1 (Figure 4F). Taken together, these results
strongly indicate that Che-1 is implicated in the regulation ofthat results in a 3 kDa larger protein (Thomas et al., 2000). As
shown in Figure 4A, a 24 hr treatment with the tetracycline E2F activity and entry into S phase of the cell cycle.
analog doxycycline (Dox) induced an expression of the exoge-
nous human Che-1 at levels comparable to the endogenous Che-1 association with E2F target gene promoters
murine Che-1. Interestingly, exogenous Che-1 downregulated is cell cycle-regulated
the level of the endogenous protein, suggesting the existence We have shown that Che-1 is able to displace HDAC1 from Rb,
of a feedback mechanism for the tight regulation of Che-1. The and this phenomenon can account, at least in part, for the
expression of exogenous Che-1 resulted in an increase of Che-1 effects of Che-1 on Rb inhibition of colony formation in tumor
levels at E2F-dependent promoters with a parallel decrease of cells. Next, we evaluated whether and when this displacement
HDAC1 levels as measured by ChIP (Figure 4B), thus confirming takes place within the cells on the endogenous proteins. To this
aim, NIH-3T3 cells were synchronized by 60 hr serum starvation,the ability of Che-1 to displace HDAC1 from Rb/E2F1 complex.
Consistently, Che-1 induction affected the regulation of E2F- harvested at 0, 8, 12, and 16 hr after serum stimulation, and
analyzed for DNA content to confirm cell cycle reentry (Figuredependent transcription of Dhfr, Tk, and cyclin E promoters
(Figure 4C). These findings, underscoring an involvement of 5A). Western blot analysis showed that Che-1 expression is
regulated during cell proliferation. Indeed, the levels of Che-1Che-1 in the regulation of E2F-dependent transcription,
prompted us to analyze the growth characteristics of induced increased at the 12 hr time point (Figure 5B), corresponding to
the G1/S transition (Figure 5A). Consistent with these results,and uninduced cells. Figure 4D shows that NIH-3T3 cells ex-
pressing the human Che-1 protein exhibited an increase rate of coimmunoprecipitation of Che-1 with anti-Rb antibody demon-
strated increased amounts of Che-1 associated to Rb duringproliferation. Furthermore, Dox treatment after serum starvation
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Figure 4. Exogenous Che-1-inducible expression affects E2F activity and cell proliferation and accelerates S phase entry
A: Lysates from NIH 3T3 cells stably transfected with inducible human Che-1, uninduced (Dox), and induced (Dox) with the tetracycline analog
doxycycline (Dox), respectively, were subjected to Western blot analysis with anti-Che-1 and anti-HDAC1 antibodies to verify protein expression. B: Uninduced
and induced NIH 3T3 cells were subjected to chromatin immunoprecipitation using specific polyclonal antibodies anti-HDAC1 or anti-Che-1. Immunoprecipi-
tates from each sample were analyzed by PCR using primers specific for the different promoters. As a control, a sample representing linear amplification
(see Figure 5D) of the total input chromatin (Input) was included in the PCRs. Additional control included a precipitation lacking specific antibodies (IgG).
C: Che-1-inducible NIH 3T3 cells were transiently transfected with 1g of the indicated luciferase reporters and treated (Dox) or not (Dox) with doxycycline
for 48 hr. Data are presented as the mean  SD from three independent experiments performed in duplicate. D: Proliferation curves of Dox and Dox
NIH 3T3 cells. The curves represent the average of three experiments with standard deviations (error bars). E: Simultaneous flow cytometric analyses for
DNA synthesis (BrdU incorporation) and DNA content (propidium iodide staining) of Dox and Dox NIH 3T3 cells were performed at the indicated times
following the end of starvation. Dox was added at the end of starvation. Percentages represent BrdU-incorporating cells. F: Immunoblot analysis of protein
lysates prepared after the readdition of serum to starved cells. Blots contain total protein lysates from Dox and Dox NIH 3T3 cells stimulated with serum
for indicated times.
this period (Figure 5B). Since Che-1 promoter characterization Next, we analyzed the presence of Che-1 on E2F target gene
promoters during cell cycle progression. As shown in Figure 5E,provided evidence that Che-1 transcription does not change
during the cell cycle (our unpublished data), it is possible that ChIP experiments performed under conditions of linear amplifi-
cation (Figure 5D) revealed that the amount of Che-1 physicallyposttranscriptional modification of Che-1 can regulate its accu-
mulation. Che-1 amino-acidic sequence showed several puta- associated with the E2F binding sites of Dhfr, cyclin A, and Tk
promoters drastically increased during cell cycle progression.tive phosphorylation sites for protein kinases CKII, PKA, and
PKC (Page et al., 1999); we therefore investigated whether A reciprocal result was observed by evaluating the amount of
HDAC1 on the same promoters. Indeed, as reported by FerreiraChe-1 is phosphorylated during the cell cycle. Measurement
of 32P incorporation at different times after serum stimulation et al. (2001a), HDAC1 expression does not change during the
cell cycle, but HDAC1 was stably bound to E2F binding sitesshowed that Che-1 is hyperphosphorylated during G1/S transi-
tion (Figure 5C), thus suggesting that phosphorylation can medi- during G0 and early G1 and gradually released during G1/S transi-
tion (Figure 5E).ate Che-1 stability.
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Figure 5. Che-1 binding to E2F target promoters is regulated during cell cycle
A: Flow cytometry cell cycle analysis of NIH 3T3 cells subjected to synchronization by serum starvation and stimulation. G1, S, and G2/M populations are
indicated as percentages of the whole population. B: Synchronized NIH 3T3 cells were lysated at the indicated times, and whole cell extracts were
immunoprecipitated with anti-Rb antibody and analyzed by Western blot using the indicated antibodies. C: Autoradiography of immunoprecipitates with
anti-Che-1 antibody from synchronized NIH 3T3 cells incubated with 32P inorganic phosphate and lysated at the indicated times. D and E: Synchronized
NIH 3T3 cells were subjected to chromatin immunoprecipitation using specific polyclonal antibodies anti-HDAC1 or anti-Che-1. Increasing amounts of input
samples (0.1, 0.2, 0.4, 0.8 l) amplified using primers specific for the different promoters (D). Immunoprecipitates from each sample were analyzed by PCR
(E). As a control, a sample representing linear amplification of the total input chromatin (Input) was included in the PCRs. Additional control included a
precipitation lacking specific antibodies (IgG).
Altogether, these results indicate that, in physiological con- Furthermore, as expected, inhibition of Che-1 expression (Fig-
ure 6E) did not change its presence on the chromatin (Figureditions, a competition between Che-1 and HDAC1 for Rb bind-
ing can occur, and this competition appears to be cell cycle- 6F), and did not affect either E2F activity or cell proliferation in
cells lacking functional pocket proteins, such as 293 cells (Fig-related.
ures 6G and 6H). These data strongly indicate a requirement
of Che-1 for E2F activity in normal proliferation, and this require-E2F activity requires Che-1 in normal cells
The results described above show that exogenous Che-1 ex- ment is mediated by the pocket proteins.
pression at physiological levels increases E2F activity and cell
proliferation. Conversely, inhibition of Che-1 should lead to a Che-1 requires Rb but not RNA pol II to recruit
E2F-responsive gene promotersdecreased E2F-dependent transcription. To test this hypothe-
sis, the small interfering RNA (siRNA) technique (Elbashir et al., We have previously shown that Che-1 binds to subunit 11 of
human RNA pol II (Fanciulli et al., 2000). It is possible that Che-12001) was used to reduce Che-1 expression in HFF human
fibroblasts. Cells transduced with double-stranded (dsRNA) oli- may associate with E2F-responsive promoters through the bind-
ing to pol II and not to pocket proteins. Therefore, to test whethergonucleotides to Che-1 (siChe-1) showed a specific reduction
of Che-1 expression compared to control, green fluorescent functional pocket proteins are required for E2F promoter bind-
ing, 293 cells were transfected either with Rb or empty vectorprotein dsRNA (siGFP)-transduced cells (Figure 6A). Che-1 re-
duction resulted in a dramatic increase of Rb/HDAC1 associa- (Figure 7A), and ChIP assays were performed with anti-Rb and
anti-Che-1 specific antibodies. As shown in Figure 7B, Che-1tion on DHFR promoter (Figure 6B), a decrease of E2F-depen-
dent transcription (Figure 6C), and cell proliferation (Figure 6D). was almost undetectable on Dhfr promoter in control cells, but
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Figure 6. E2F activity requires Che-1 in normal cells
A and E: Silencing of Che-1 in HFF human fibroblasts (A) and 293 cells (E). Western blots of cells transfected with green fluorescent protein (GFP) siRNA or
Che-1 siRNA probed with anti-Che-1 antibody. The blots were stripped and reprobed with anti--tubulin antibody. B and F: HFF human fibroblasts (B) and
293 cells (F) were transiently transfected with GFP siRNA or Che-1 siRNA and subjected to chromatin immunoprecipitation using specific antibodies anti-
HDAC1 or anti-Che-1. Immunoprecipitates from each sample were analyzed by PCR using primers specific for the E2F binding sites of human Dhfr gene
promoter. As a control, a sample representing linear amplification (see Figure 3B) of the total input chromatin (Input) was included in the PCRs. Additional
control included a precipitation lacking specific antibodies (IgG). C and G: HFF human fibroblasts (C) and 293 cells (G) were transiently transfected with
GFP siRNA or Che-1 siRNA and 1 g of the indicated luciferase reporters. Data are presented as the mean  SD from three independent experiments
performed in duplicate. D and H: Cell proliferation analyses of HFF human fibroblasts (D) and 293 cells (H) transiently transfected with GFP siRNA or Che-1
siRNA. Data are presented as the mean  SD from three independent experiments performed in duplicate.
became present in Rb overexpressing cells, indicating that the mutantChe-1 bound GST-Rb in vitro, it was not able to associ-
ate with Rb on this promoter (Figure 7D) and did not affectpresence of Rb mediates Che-1 binding to E2F-dependent pro-
moters. To evaluate whether Che-1 could be recruited on these HDAC1 recruitment (Figure 7D) and Rb activity (Figure 7E).
These results indicate that Che-1 requires the pocket proteins,promoters through its association with pol II, we generated a
new Che-1 mutant, -zip, lacking the whole leucin zipper (aa rather than pol II, to bind E2F target gene promoters.
270–298), the region responsible for RNA pol II binding (Fanciulli
et al., 2000). When transfected into NIH-3T3 cells, this mutant Overexpression of Che-1 induces quiescent cells
to enter S phasewas unable to bind pol II (Figure 7C) but still retained the ability to
displace HDAC1 when recruited on a E2F-responsive promoter, Previous reports have shown that E2F1 overexpression can
induce DNA synthesis in the absence of serum in otherwise(Figure 7D) and to counteract Rb activity when cotransfected
in Saos-2 cells (Figure 7E). Surprisingly, although the Che-1 quiescent cells (Johnson et al., 1993; Kowalik et al., 1995). Thus,
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Figure 7. Che-1 requires Rb but not RNA pol II to recruit E2F-responsive gene promoters
A: Lysates from 293 cells transiently transfected with empty vector or pCMV Rb, respectively, were subjected to Western blot analysis with anti-Rb and anti-
Che-1 antibodies to verify protein expression. B: Che-1 requires Rb to bind E2F target gene promoters. Lysates from 293 cells transfected as described in
A were subjected to chromatin immunoprecipitation using specific antibodies anti-Rb or anti-Che-1. Immunoprecipitates from each sample were analyzed
by PCR using primers specific for the E2F binding sites of human Dhfr gene promoter. As a control, a sample representing linear amplification (see Figure
3B) of the total input chromatin (Input) was included in the PCRs. Additional control included a precipitation lacking specific antibodies (IgG). C: NIH 3T3
cells transiently transfected with the indicated expression vectors were lysated, immunoprecipitated with anti-myc antibody, and analyzed by Western
blot using the indicated antibodies. D: Che-1 does not require RNA pol II to bind E2F-target gene promoters. Lysates from NIH 3T3 cells transfected with
the indicated expression vectors were subjected to chromatin immunoprecipitation using anti-HDAC1 and anti-myc antibodies. Immunoprecipitates from
each sample were analyzed by PCR using primers specific for the E2F binding sites of murine Dhfr gene promoter. Controls were the same described in B.
E: -zip, but not Che-1, inhibits Rb. Saos-2 cells were transiently transfected with 1 g Dhfr-luciferase reporter and, where indicated, 100 ng pCMV E2F1
expression vector, 200 ng pCMV Rb, and 1 g of myc-Che-1, myc-Che-1, or myc--zip, respectively. The total amount of transfected DNA was normalized
with pCMV empty vector (). Data are presented as the mean  SD from three independent experiments performed in duplicate.
we evaluated whether comparable effects could be obtained Discussion
by overexpressing Che-1 or its mutants in serum-starved cells.
We had previously provided evidence that a novel human pro-NIH-3T3 cells were made quiescent as described above and
tein, Che-1, interacts with Rb protein, and this binding affectstransiently transfected with either myc-tagged Che-1, Che-1,
the growth-suppressing function of Rb by relieving its inhibition-zip, or empty vector as negative control. The addition of serum
of E2F1 transcriptional activity (Fanciulli et al., 2000). One ofto empty vector-transfected cells was used as positive control
the important biological functions of the Rb family is to regulate(Figure 8A). After 24 hr from transfection, BrdU was added to
the expression of genes required for cell cycle progression andthe media, and cells were incubated for additional 6 hr before
DNA synthesis. Rb family members utilize the pocket domain
fixation and immunofluorescence staining with anti-BrdU anti-
to recruit HDAC activity and to repress transcription of genes
body (Figure 8B). Che-1 overexpression substantially increased in early G1 phase, or when cells exit from the cell cycle (Brehm
the fraction BrdU positive cells (Figure 8C), indicating that Che-1 et al., 1998; Magnaghi-Jaulin et al., 1998; Ferreira et al., 1998;
can stimulate DNA synthesis. Similar results were obtained with Stiegler et al., 1998). During G1, Rb phosphorylation by several
-zip, but not with Che-1 (Figure 8C) deletion mutants. Thus, different cyclin-Cdk combinations leads to successive intramo-
Che-1 plays an important role in progression into S phase, and lecular interactions that block HDAC binding to the pocket do-
this capacity is associated with HDAC1 displacement from Rb main and transcriptional repression (Harbour et al., 1999). Simi-
larly, interaction of Rb family members with viral transforming(Figure 8D).
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Figure 8. Che-1 induces DNA synthesis in serum-starved cells
A: Lysates from NIH 3T3 serum-starved cells transiently transfected with empty vector (w/o serum) or with the indicated myc-Che-1 constructs were subjected
to Western blot analysis with anti-myc antibody to verify Che-1 expression. B: NIH 3T3 serum starved cells transiently transfected as in A visualized for BrdU
incorporation by indirect immunofluorescence performed using an anti-BrdU monoclonal antibody. C: Quantification of BrdU-positive NIH 3T3 cells. Data
are presented as the mean  SD from three independent experiments. D: Model to explain Che-1-mediated Rb repression. Histone deacetylase is recruited
during G0/G1 phases to promoters that contain E2F/pocket protein complexes through an interaction with pocket proteins. Histone deacetylase then
modifies the histones proximal to the promoter, causing transcriptional silencing. During G1/S progression, Che-1 displaces HDAC1 from pocket proteins,
allowing transcriptional activation.
proteins results in loss of HDAC binding (Brehm et al., 1998; two regions of interaction with Rb (aa 305–323) contains features
that are conserved among viral Rb binding proteins andMagnaghi-Jaulin et al., 1998). Here, we present evidence that
the binding of Che-1 to Rb affects the growth suppression HDAC1-3, with importance predicted by crystallographic data
and supported by peptide competition experiments (Jones etfunction of Rb by interfering with HDAC1 recruitment by Rb,
and that Che-1 overexpression is capable of inducing S phase al., 1990; Lee et al., 1998). These features suggest that Che-1
would bind Rb with high affinity and could compete with otherin otherwise quiescent cells. In this way, Che-1 appears to
behave like DNA virus oncoproteins. Rb binding proteins.
In order to analyze the pattern of Che-1 expression duringChe-1 is a ubiquitously expressed nuclear protein (Fanciulli
et al., 2000; Thomas et al., 2000). The studies performed on the cell cycle, NIH-3T3 cells were synchronized by serum starva-
tion. We found that during G1/S transition, Che-1 is phosphory-this protein and its homologs in rat and mice strongly support
the idea that Che-1 is involved in the regulation of gene tran- lated, and its expression levels increased. Importantly, this aug-
ment of expression produced a larger amount of Che-1 bound toscription and cell proliferation. Che-1 directly interacts with Rb
and the core of RNA pol II (Fanciulli et al., 2000), it is downregu- Rb (Figure 5B), suggesting that these modifications can regulate
HDAC1 displacement. Consistent with these results, the amountlated by TGF- (Lindfors et al., 2000), and when fused to the
GAL4 DNA binding domain, it transactivates GAL4 target report- of Che-1 associated with E2F responsive gene promoters in-
creased as cells progressed through the S phase, whereas aers (Page et al., 1999). The knockout of Traube, the murine
Che-1, blocks early embryonic development and reduces cell reciprocal result was obtained when the presence of HDAC1
on the same promoters was assessed. This supports the hy-proliferation (Thomas et al., 2000). Che-1 contains a leucine
zipper structure, several potential phosphorylation sites for dif- pothesis that binding of HDAC1 and Che-1 to Rb are mutually
exclusive events, regulated during the cell cycle progression,ferent kinases, and three nuclear receptor binding LXXLL con-
sensus sequences (Heery et al., 1997; Torchia et al., 1997). and that the negative role exerted by HDAC1 on the transcription
of E2F-responsive genes can be counteracted by Che-1. AsAlthough Che-1 does not posses a LXCXE motif, one of the
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(DMEM) supplemented with 10% fetal bovine serum. To produce a prolifera-shown Figure 5E, the association of Che-1 with cyclin A pro-
tion block, NIH 3T3 cells were cultured for 60 hr in medium containing 0.2%moter is detectable during G1 phase and increases during G1/S
fetal bovine serum. DNA distribution analysis was performed according totransition, consistent with a gradual disappearance of HDAC1
standard procedures, measuring the DNA content by an Epics XL analyzer
on this promoter. Cyclin A is an important protein involved in (Coulter Corporation). BES-calcium phosphate precipitation was used to
the cell cycle progression, and its expression is tightly regulated transiently transfect cells as previously described (Fanciulli et al., 2000).
Transfection efficiency ranged between 40% and 60% of cells.during S phase; therefore, it is also possible that besides the
presence of Che-1, some other factor might be required for the
Metabolic labelingexpression of this protein.
NIH 3T3 cells were synchronized by serum starvation, stimulated by serumTwo studies have recently demonstrated that E2F target
for various times, and incubated for 3 hr with 0.5 mCi/ml [32P] inorganic
genes are bound by distinct E2F-pocket protein complexes that phosphate (Amersham) in phosphate-free medium (Sigma) before immuno-
change as cells progress through the cell cycle (Wells et al., precipitation of Che-1.
2000; Takahashi et al., 2000). Thus, it is possible that the associ-
Inducible Che-1 overexpressionation of HDAC1 and Che-1 detected on these promoters may
Stable cell clones expressing Che1 in a conditional way (tetracycline-regu-involve all three members of the pocket family and not only Rb.
lated transactivation system [Gossen and Bujard, 1992; Gossen et al., 1995])Overexpression of Che-1 into serum-starved NIH-3T3 cells
were obtained by transfecting the construct pTRE-Ires-GFP-Che1 in an NIH
induced S phase entry, and viewed from the perspective of a 3T3 cell line stably expressing rtTA (3T3-tetOn) and carrying resistance to
protein that can activate E2F1 by overcoming Rb block, an puromycin, obtained by Dr. Caruso and Dr. Tirone (INMM-CNR, Rome, Italy).
induction of cellular DNA synthetic capacity in quiescent cells is Details of stable clones production are provided in the Supplemental Data
at http://www.cancercell.org/cgi/content/full/2/5/387/DC1. Reentry of cellsa rational effect. Nevertheless, we cannot exclude the possibility
into the cell cycle after starvation was analyzed by flow cytometry usingthat Che-1 can exert this induction by other mechanisms.
BrdU incorporation as previously described (Biroccio et al., 2002).The highly acidic amino-terminal region of Che-1 is found
in several proteins associated with a chromatin remodeling func- Immunoprecipitations and Western blot analysis
tion during transcription, including the MOZ family proteins (Bor- Cells were rinsed three times with ice-cold PBS, harvested, centrifuged at
row et al., 1996; Champagne et al., 1999) and BRCA1 (Hu et 4	C, and cell pellets lysed by incubation at 0	C for 30 min in 300 l lysis
buffer (50 mM Tris-HCl [pH 8.0], 150 mM NaCl, 10% glycerol, 0.5 mM EDTA,al., 1999). Consistent with this observation, preliminary research
0.5 mM EGTA, 100 mM NaF, 3 mM NaOV4, 10 nM okadaic acid, 1 mMin our hands indicates that this region, but not the whole protein,
PMSF, 10 mg/ml leupeptin) supplemented with 1% NP40. Supernatantseven if it does not directly contact DNA, strongly activates tran-
were cleared by centrifugation, precleared using 20 l protein A/protein Gscription, suggesting a potential involvement in the modification
beads (Santa Cruz), and immunoprecipitated by standard procedures using
of the chemical and structural composition of chromatin. anti-Che-1, anti-Rb (C15, Santa Cruz) polyclonal antibodies or anti-myc
Finally, the pocket region of Rb mediates interaction with (9e10, Invitrogen) monoclonal antibody. Western blots were prepared by
several chromatin remodeling factors (Ferreira et al., 2001b); standard procedures using the following rabbit polyclonal antibodies: anti-
Che-1, anti-Rb, anti-p107 (C18, Santa Cruz), anti-p130 (C20, sc317, Santathus, it is possible that, besides HDAC1, Che-1 may displace
Cruz), anti RNA Pol II (C-21, Santa Cruz), anti-cyclin D1 (C20, sc307, Santaother proteins from Rb. Therefore, a deeper characterization of
Cruz), anti-cyclin A (C19, Santa Cruz), anti-HDAC1 (Upstate Biotechnol-Che-1 functions could amplify this novel pathway of regulation
ogy), or anti- Tubulin (TU-02, Santa Cruz) and anti-myc monoclonal antibod-
of Rb activity, exerted by the control of the recruitment of chro- ies. Immunoreactivity was detected by ECL chemiluminescence reaction
matin remodeling enzymes, and in addition could shed light on (Amersham).
the role played by Che-1 in the regulation of transcription and
BrdU incorporation analysiscell proliferation.
NIH 3T3 cells were growth arrested as described above and transfected
with myc-tagged wild-type Che-1, Che-1, -zip, or with empty vector andExperimental procedures
placed in DMEM medium containing 0.2% fetal bovine serum for additional
24 hr. Growth-arrested cells transfected with empty vector were placed inPlasmids
medium supplemented with 10% fetal calf serum and used as positiveMyc-tagged Che-1, Rb, and E2F1 mammalian expression vectors, GST-Rb
control. Immunofluorescence staining for BrdU was performed as previouslyfusion protein, and DHFR-luciferase vector have been previously described
described (Crescenzi et al., 1995).(Fanciulli et al., 2000).
To generate pTRE-IRES-EGFP-Che-1, the region of pIRES2-EGFP vec-
tor (Clontech) corresponding to cytomegalovirus immediate early (CMV) pro- Pull-down analysis
moter was restricted and substituted with the Tet-responsive PhCMV-1 BL21 bacteria strains were transformed with GST fusion protein constructs
promoter region removed from pTRE vector (Clontech). The DNA fragment and the proteins purified on glutathione-Sepharose resin (Pharmacia). For
containing full-length ORF of human Che-1 and the Tag-Flag was then in vitro binding assays, comparable amounts of resin-bound GST fusion
adapted in this resulting novel vector. Plasmid expressing bacterial recombi- proteins were incubated with 500 g of cell lysates in NETN buffer (20 mM
nant 6xHis-Che-1 was produced by cloning the complete ORF of Che-1 Tris-HCl [pH 8.0], 100 mM NaCl, 1 mM EDTA, and 0.5% NP-40) for 1 hr at
into pQE30 bacterial expression vector (Quiagen). The complete ORF of 4	C. The resins were then pelleted and extensively washed in the same
human HDAC1 was generated by PCR and cloned into myc-tagged expres- buffer. The bound proteins were separated by SDS-PAGE, and the gels
sion vector pCS2-MT. GST-Rb 1–379 was kindly provided by Dr. Wang were analyzed by Western blot using anti-myc monoclonal antibody. Immu-
(University of California, San Diego). Other deletions of Rb and its mutations noreactivity was detected by ECL chemiluminescence reaction (Amersham).
fused to GST were generously provided by Dr. Caruso (CNR-IBC, Rome). In vitro transcription and translation were carried out with TNT-coupled
Mutagenesis of myc-Che-1 were performed using the Quickchange Muta- reticulocyte lysate systems (Promega) and L-[35S]methionine (
1,000 Ci/
genesis system (Stratagene). mmol; Amersham) as previously described (Fanciulli et al., 2000).
Cell culture and transfections Peptide synthesis
Saos-2 human osteosarcoma cells, 293 human transformed embryonal kid- Peptides were prepared in a Vega Peptide Synthetizer Model 1000, using
ney cells, HFF human fibroblasts (kind gift from Dr. Lauren Wood), and NIH Fmoc chemistry with protected amino acids purchased from Inalco, Milan.
At the end of the synthesis, peptides were cleaved and deprotected in a3T3 mouse fibroblasts were grown in Dulbecco’s modified Eagle’s medium
CANCER CELL : NOVEMBER 2002 397
A R T I C L E
restores tumorigenicity in melanoma-derived c-Myc low-expressing clones.mixture of trifluoroacetic acid/anisole (19:1) for 60 min, precipitated with
Oncogene 21, 3001–3019.cold ether, recovered by centrifugation, and purified by HPLC. The correct
amino acid composition was confirmed by amino acid analysis by HPLC/ Borrow, J., Stanton, V.J., Andresen, J., Becher, R., Behm, F., Chaganti, R.,
fluorescence after complete hydrolysis of 50 g of samples with 6 N HCl Civin, C., Disteche, C., Dube, I., Frischauf, A., et al. (1996). The translocation
at 108	C for 24/48 hr. Peptides sequence: Che-1 305–323: DGTKPNTESEEIS t(8;16) (p11;p13) of acute myeloid leukemia fuses a putative acetyltranferase
SEDDEL; HDAC1: SDKRIACEEEFSDSEE; SV40 Large T: NEENLFCSEEMPS to the CREB-binding protein. Nat. Genet. 14, 33–41.
SDD; Control: LKGAKPIRPVVVKAPPA.
Brehm, A., Miska, E.A., McCance, D.J., Reid, J.L., Bannister, A., and Kouzar-
ides, T. (1998). Retinoblastoma protein recruits histone deacetylase to re-Deacetylase assay
press transcription. Nature 391, 597–601.Deacetylase assays were performed utilizing a Histone Deacetylase Assay
Kit (Upstate Biotechnology) according to the manufacturer’s instructions. Champagne, N., Bertos, N., Pelletier, N., Wang, A., Vezmar, M., Yang, Y.,
All experiments were performed at least three times and samples were Heng, H., and Yang, X.-J. (1999). Identification of of a human histone acetyl-
assayed in duplicate. transferase related to monocitic leukemia zinc finger protein. J. Biol. Chem.
274, 28528–28536.
Chromatin immunoprecipation assay (ChIP)
Crescenzi, M., Soddu, S., and Tato`, F. (1995). Mitotic cycle reactivation inChIP assay was performed using the acetyl-histone H3 immunoprecipation
terminally differentiated by adenovirus infection. J. Cell. Physiol. 162, 26–35.assay kit (Upstate Biotechnology) according to the manufacturer’s instruc-
tions. For ChIP experiments conducted with anti-HDAC1 and anti-Che-1 DeCaprio, J.A., Ludlow, J.W., Figge, J., Shew, J.Y., Huang, C.M., Lee, W.H.,
polyclonal antibodies, conditions were as reported by Nissen and Yamamoto Marsilio, E., Paucha, E., and Livingston, D.M. (1988). SV40 large tumor
(2000). In each experiment, linearity of the signal was insured by amplifying antigen forms a specific complex with the product of the retinoblastoma
susceptibility gene. Cell 54, 275–283.increasing amounts of the template DNA (see Figures 3B and 5D). Generally,
DNA representing 0.005% to 0.01% of the total chromatin sample (input)
DeGregori, J., Leone, G., Miron, A., Jakoi, L., and Nevins, J.R. (1997). Distinctor 1% to 10% of the immunoprecipitated was amplified using promoter-
roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad.
specific primers whose sequences are provided in Supplemental Data at
Sci. USA 94, 7245–7250.
http://www.cancercell.org/cgi/content/full/2/5/387/DC1. Immunoprecipita-
tion with no specific immunoglobulins (Santa Cruz) was performed as a Dyson, N. (1998). The regulation of E2F by pRB-family proteins. Genes Dev.
12, 2245–2262.negative control. PCR conditions were: 1  95	C for 2 min, followed by 30
cycles at 95	C for 1 min, 60	C or 64	C for 1 min, and 72	C for 2 min.
Elbashir, S.M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl,
T. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in
RT-PCR analysis cultured mammalian cells. Nature 411, 494–498.
For semiquantitative RT-PCR analysis, Saos-2 cells were transfected with
Fanciulli, M., Bruno, T., Di Padova, M., De Angelis, R., Iezzi, S., Iacobini, C.,the indicated expression vectors, and 36 hr after transfection, total RNA was
Floridi, A., and Passananti, C. (2000). Identification of a novel partner of RNAisolated using TRIZOL reagent (Life Technologies). RT-PCR was performed
polymerase II subunit 11, Che-1, which interacts with and affects the growthusing a Platinum quantitative RT-PCR kit (Invitrogen) following the manufac-
suppression function of Rb. FASEB J. 14, 904–912.turer’s instructions. PCR products were separated on a 2% agarose gel.
PCR conditions were: 1  95	C for 5 min., followed by 25 cycles at 95	C Ferreira, R., Magnaghi-Jaulin, L., Robin, P., Harel-Bellan, A., and Trouche,
for 1 min, 55	C for 1 min., and 72	C for 2 min. Sequences of primers employed D. (1998). The three members of the pocket proteins family share the ability
in RT-PCR analysis are provided in the Supplemental Data. to repress E2F activity through recruitment of a histone deacetylase. Proc.
Natl. Acad. Sci. USA 95, 10493–10498.
RNA interference in human cells
Ferreira, R., Naguibneva, I., Mathieu, M., Ait-Si-Ali, S., Robin, P., Pritchard,The 22 nucleotide siRNA duplexes corresponding to nucleotides 191–212
L.L., and Harel-Bellan, A. (2001a). Cell cycle-dependent recruitment ofof human Che-1 sequence and to nucleotides 122–143 of the negative
HDAC-1 correlates with deacetylation of histone H4 on an Rb-E2F targetcontrol green fluorescent protein (GFP) sequence were synthesized by Xera-
promoter. EMBO Rep. 21, 794–799.gon. RNA interference was performed as described by Elbashir et al. (2001).
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